Hyderabad based company, Biological E has announced that it will produce Johnson & Johnson Covid-19 vaccine alongside its own candidate. The managing director of the pharma company announced on Tuesday, the production of this vaccine in India can fulfil all the demands of the vaccines in the nation and can bring a break-even point for jabs. The pharma company is aiming at 600 million doses a year to produce in India alongside their own vaccine. India has been facing a severe shortage of jabs since the third phase of the coronavirus vaccination drive has kickstarted. Watch out for the video for more information.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting